The novel SIRT6 activator MDL-811 ameliorated neuroinflammation and ischemic injury via the zeste homolog 2/FOXC1 axis [97], highlighting the value of MDL-811 for treating aging-related ischemic stroke. The gene discussed is SIRT6; the disease is ischemic stroke.